Pulmonary Function, Muscle Strength, Time to Extubation and Quality of Recovery in the Post Anesthesia Care Unit After Reversal of Neuromuscular Blockade With Neostigmine or Sugammadex.
Latest Information Update: 12 May 2022
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 13 May 2020 Results published in the Canadian Journal of Anesthesia
- 17 Apr 2018 Status changed from recruiting to completed.
- 06 Nov 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.